全文获取类型
收费全文 | 11866篇 |
免费 | 960篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 190篇 |
儿科学 | 266篇 |
妇产科学 | 189篇 |
基础医学 | 1630篇 |
口腔科学 | 163篇 |
临床医学 | 1294篇 |
内科学 | 2449篇 |
皮肤病学 | 161篇 |
神经病学 | 1120篇 |
特种医学 | 415篇 |
外科学 | 1857篇 |
综合类 | 163篇 |
一般理论 | 27篇 |
预防医学 | 1031篇 |
眼科学 | 181篇 |
药学 | 821篇 |
中国医学 | 7篇 |
肿瘤学 | 898篇 |
出版年
2024年 | 13篇 |
2023年 | 118篇 |
2022年 | 174篇 |
2021年 | 410篇 |
2020年 | 233篇 |
2019年 | 397篇 |
2018年 | 522篇 |
2017年 | 369篇 |
2016年 | 356篇 |
2015年 | 377篇 |
2014年 | 531篇 |
2013年 | 575篇 |
2012年 | 997篇 |
2011年 | 979篇 |
2010年 | 572篇 |
2009年 | 492篇 |
2008年 | 798篇 |
2007年 | 790篇 |
2006年 | 738篇 |
2005年 | 734篇 |
2004年 | 684篇 |
2003年 | 515篇 |
2002年 | 519篇 |
2001年 | 93篇 |
2000年 | 62篇 |
1999年 | 87篇 |
1998年 | 89篇 |
1997年 | 75篇 |
1996年 | 64篇 |
1995年 | 49篇 |
1994年 | 53篇 |
1993年 | 42篇 |
1992年 | 30篇 |
1991年 | 30篇 |
1990年 | 34篇 |
1989年 | 33篇 |
1988年 | 28篇 |
1987年 | 26篇 |
1986年 | 26篇 |
1985年 | 24篇 |
1984年 | 16篇 |
1983年 | 17篇 |
1982年 | 11篇 |
1981年 | 16篇 |
1980年 | 9篇 |
1976年 | 6篇 |
1972年 | 4篇 |
1970年 | 4篇 |
1969年 | 6篇 |
1966年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. 总被引:9,自引:0,他引:9
Ryohei Sasaki Ritsuko Komaki Homer Macapinlac Jeremy Erasmus Pamela Allen Kenneth Forster Joe B Putnam Roy S Herbst Cesar A Moran Donald A Podoloff Jack A Roth James D Cox 《Journal of clinical oncology》2005,23(6):1136-1143
PURPOSE: To determine whether the standardized uptake value (SUV) of [(18)F]fluorodeoxyglucose uptake by positron emission tomography could be a prognostic factor for non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS: One hundred sixty-two patients with stage I to IIIb NSCLC were analyzed. Overall survival (OS), disease-free survival (DFS), distant metastasis-free survival (DMFS), and local-regional control (LRC) were calculated by the Kaplan-Meier method and evaluated with the log-rank test. The prognostic significance was assessed by univariate and multivariate analyses. RESULTS: There were 93 patients treated with surgery and 69 patients treated with radiotherapy. A cutoff of 5 for the SUV for the primary tumor showed the best discriminative value. The SUV for the primary tumor was a significant predictor of OS (P = .02) in both groups. Low SUVs (= 5.0) showed significantly better DFS rates than those with high SUVs (> 5.0; surgery group, P = .02; radiotherapy group, P = .0005). Low SUVs (= 5.0) indicated a significantly better DFS than those with high SUVs (> 5.0; stage I or II, P = .02; stage IIIa or IIIb, P = .004). However, using the same cutoff point of 5, the SUV for regional lymph nodes was not a significant indicator for DFS (P = .19), LRC (P = .97), or DMFS (P = .17). The multivariate analysis showed that the SUV for the primary tumor was a significant prognostic factor for OS (P = .03) and DFS (P = .001). CONCLUSION: The SUV of the primary tumor was the strongest prognostic factor among the patients treated by curative surgery or radiotherapy. 相似文献
102.
103.
104.
105.
106.
Lucca R. Policastro Isabela Dolci Andre S. Godoy Jos V. J. Silva Júnior Uriel E. A. Ruiz Igor A. Santos Ana C. G. Jardim Kirandeep Samby Jeremy N. Burrows Timothy N. C. Wells Laura H. V. G. Gil Glaucius Oliva Rafaela S. Fernandes 《Viruses》2022,14(7)
Chikungunya virus (CHIKV) is the causative agent of chikungunya fever, a disabling disease that can cause long-term severe arthritis. Since the last large CHIKV outbreak in 2015, the reemergence of the virus represents a serious public health concern. The morbidity associated with viral infection emphasizes the need for the development of specific anti-CHIKV drugs. Herein, we describe the development and characterization of a CHIKV reporter replicon cell line and its use in replicon-based screenings. We tested 960 compounds from MMV/DNDi Open Box libraries and identified four candidates with interesting antiviral activities, which were confirmed in viral infection assays employing CHIKV-nanoluc and BHK-21 cells. The most noteworthy compound identified was itraconazole (ITZ), an orally available, safe, and cheap antifungal, that showed high selectivity indexes of >312 and >294 in both replicon-based and viral infection assays, respectively. The antiviral activity of this molecule has been described against positive-sense single stranded RNA viruses (+ssRNA) and was related to cholesterol metabolism that could affect the formation of the replication organelles. Although its precise mechanism of action against CHIKV still needs to be elucidated, our results demonstrate that ITZ is a potent inhibitor of the viral replication that could be repurposed as a broad-spectrum antiviral. 相似文献
107.
Jeremy D. Rubinstein Karen Burns Michael Absalon Carolyn Lutzko Tom Leemhuis Sharat Chandra Patrick J. Hanley Michael D. Keller Stella M. Davies Adam Nelson Michael Grimley 《Pediatric blood & cancer》2020,67(3)
Children with ataxia telangiectasia (AT), a primary immunodeficiency caused by mutations in ATM, which is critical for repairing DNA defects, are at risk for the development of hematologic malignancy, frequently driven by infection with Epstein‐Barr virus (EBV). Conventional chemotherapy is poorly tolerated by patients with AT, with excessive toxicity even when doses are reduced. Here, we report on two patients with AT and EBV‐positive neoplasms who were treated with EBV‐targeted viral‐specific T cells (VST). One patient had a prolonged complete response to VSTs while the other had a partial response. Therapy was well tolerated without infusion toxicity or graft‐versus‐host disease. 相似文献
108.
Monika Zdanyte Peter Martus Jeremy Nestele Alexander Bild Lars Mizera Andreas Glatthaar lvaro Petersen Uribe Frederic Emschermann JessicaKristin Henes Tobias Geisler Karin Müller Meinrad Gawaz Dominik Rath 《Clinical cardiology》2022,45(9):943
BackgroundCardiovascular risk factors and comorbidities are highly prevalent among COVID‐19 patients and are associated with worse outcomes.HypothesisWe therefore investigated if established cardiovascular risk assessment models could efficiently predict adverse outcomes in COVID‐19. Furthermore, we aimed to generate novel risk scores including various cardiovascular parameters for prediction of short‐ and midterm outcomes in COVID‐19.MethodsWe included 441 consecutive patients diagnosed with SARS‐CoV‐2 infection. Patients were followed‐up for 30 days after the hospital admission for all‐cause mortality (ACM), venous/arterial thromboembolism, and mechanical ventilation. We further followed up the patients for post‐COVID‐19 syndrome for 6 months and occurrence of myocarditis, heart failure, acute coronary syndrome (ACS), and rhythm events in a 12‐month follow‐up. Discrimination performance of DAPT, GRACE 2.0, PARIS‐CTE, PREDICT‐STABLE, CHA2‐DS2‐VASc, HAS‐BLED, PARIS‐MB, PRECISE‐DAPT scores for selected endpoints was evaluated by ROC‐analysis.ResultsOut of established risk assessment models, GRACE 2.0 score performed best in predicting combined endpoint and ACM. Risk assessment models including age, cardiovascular risk factors, echocardiographic parameters, and biomarkers, were generated and could successfully predict the combined endpoint, ACM, venous/arterial thromboembolism, need for mechanical ventilation, myocarditis, ACS, heart failure, and rhythm events. Prediction of post‐COVID‐19 syndrome was poor.ConclusionRisk assessment models including age, laboratory parameters, cardiovascular risk factors, and echocardiographic parameters showed good discrimination performance for adverse short‐ and midterm outcomes in COVID‐19 and outweighed discrimination performance of established cardiovascular risk assessment models. 相似文献
109.
Composite regulatory signature database (CRSD), a self-developed comprehensive Web server for composite regulatory signature discovery, used to compare the published microarray data with our data on patients with uterine leiomyoma treated with or without GnRH analogue (GnRH-a), revealed that the focal adhesion, mitogen-activated protein kinase (MAPK), CXC chemokine receptor 4/stromal-derived factor-1 (CXCR4/SDF-1), T-cell receptor, integrin, vascular endothelial growth factor (VEGF), GnRH, and transforming growth factor-beta (TGF-beta) signaling pathways are highly expressed in uterine leiomyoma and significantly down-regulated after GnRH-a treatment. According to the results these signaling pathways could be involved in inflammation, proliferation, and remodeling processes of leiomyoma development and possibly in the regression of leiomyoma after GnRH-a treatment, which might improve our understanding of the mechanisms of leiomyoma formation and help us to find novel drug targets or specific markers for diagnosis and prognosis in uterine leiomyoma. 相似文献
110.
The application of in vitro maturation (IVM) of oocytes as a technology to assist animal production and clinical infertility treatment remains poor because of the reduced developmental competence of oocytes after IVM, despite several decades of research. Reduced meiotic maturation rates, fertilization rates, and blastocyst production reveal short-term developmental insufficiency of oocytes when compared with in vivo-matured counterparts. However, there is an increasing body of evidence that demonstrates the capacity of IVM efficiency to be improved, some of which is reviewed here. Of more concern is the role that IVM of oocytes may play in causing or accentuating long-term development and health of fetuses and neonates after in vitro production of embryos and embryo transfer. This is a largely unexplored area, yet the application of such techniques, especially the safety of clinical IVM, is significant and requires monitoring before acceptance as a routine procedure. 相似文献